Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trialThierry Conroy, Antoine Adenis, Pierre Michel et al.|The Lancet Oncology|2014Cited by 446
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensusThomas Zilli, Claus Belka, Pierre Blanchard et al.|Radiotherapy and Oncology|2022Cited by 98
Urinary Organs at Risk for Prostate Cancer External Beam Radiation Therapy: Contouring Guidelines on Behalf of the Francophone Group of Urological Radiation TherapyJennifer Le Guévelou, Paul Sargos, Thomas Zilli et al.|Practical Radiation Oncology|2024Cited by 14
Sexual Structure Sparing for Prostate Cancer Radiotherapy: A Systematic ReviewJennifer Le Guévelou, I. Latorzeff, Ulrike Schick et al.|European Urology Oncology|2023Cited by 12